Prot# VEL-03-082: A Phase I/II Trial of Combination Bortezomib (VELCADE®) and Gemcitabine Therapy for Patients with Relapsed or Refractory Aggressive B- and T -Cell Non-Hodgkin's Lymphoma (NU Prot# NU 04H4)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/8/0510/31/14

Funding

  • Millennium Pharmaceuticals, Inc. (VEL-03-082 / NU 04H4)